Residency · Iowa City, IA
Sponsored by University of Iowa Health Care Medical Center
Mitochondrial dysfunction in neurodegenerative disorders.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024 · 292 citations · Bharatendu Chandra
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 90 citations · Alpa Sidhu
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Neurology · 2024 · 113 citations · Katherine Mathews
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study).
Annals of neurology · 2021 · 248 citations · Katherine Mathews
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension.
Movement disorders : official journal of the Movement Disorder Society · 2023 · 95 citations · Katherine Mathews
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study.
Journal of medical genetics · 2024 · 42 citations ·
Gene therapy and gene correction: targets, progress, and challenges for treating human diseases.
Gene therapy · 2022 · 105 citations · Val Sheffield
Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data.
Annals of clinical and translational neurology · 2024 · 44 citations · Katherine Mathews